| [Flash Point] 145 | |
| [Flash Point] 303 | |
| [Fire Fighting] Extinguish using Water spray. Carbon dioxide, dry chemical powder, or appropriate foam. Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes. | |
| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. To extinguish fire use water spray, dry chemical, carbon dioxide, or chemical foam. | |
| [Ingestion] Get medical aid. Wash mouth out with water. | |
| [Ingestion] If swallowed, wash out mouth with water provided person is conscious. Call a physician. | |
| [Inhalation] If inhaled, remove to fresh air. If breathing becomes difficult, call a physician. | |
| [Inhalation] Causes respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. | |
| [Inhalation] Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. | |
| [Skin] Causes skin irritation. | |
| [Skin] Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Skin] In case of contact, immediately wash skin with soap and copious amounts of water. | |
| [Eyes] Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. | |
| [Eyes] In case of contact with eyes, flush with copious amounts of water for at least 15 minutes. Assure adequate flushing by separating the eyelids with fingers. Call a physician. | |
| [Eyes] Causes eye irritation. | |
| [Storage] Keep tightly closed. | |
| [Storage] Store in a cool, dry place. Store in a tightly closed container. | |
| [Handling] Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. | |
| [Ingestion] May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. | |
| [Inhalation] May be harmful if inhaled. Material may be irritating to mucous membranes and upper respiratory tract. | |
| [Skin] May cause skin irritation. May be harmful if absorbed through the skin. | |
| [Eyes] May cause eye irritation. | |
| [Ingestion] May be harmful if swallowed. | |
| [Hazards] Emits toxic fumes under fire conditions. | |
| [EC Risk Phrase] R 36/37/38 | |
| [EC Safety Phrase] S 26 36 | |
| [EC Safety Phrase] 22 24/25 | |
| [Personal Protection] Protective gloves. Chemical safety goggles. | |
| [Personal Protection] Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. | |
| [Respirators] Wear dust mask. | |
| [Respirators] Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary. | |
| [Exposure Effects] Avoid contact and inhalation. Target organ(s): Endocrine system. | |
| [Appearance] Beige - light brown powder. | |
| [Solubility in water] Insoluble | |
| [Solubility in water] Very soluble | |
| [Melting Point] 274 | |
| [Boiling Point] 317 | |
| [Boiling Point] 577 | |
| [Vapor Pressure] 0.0002 (25 C) | |
| [Vapor Pressure] 1E-15 (25 C) | |
| [pKa/pKb] 2.08 (pKa) | |
| [pKa/pKb] 12.69 (pKs) | |
| [Partition Coefficient] 1.67 | |
| [Heat Of Vaporization] 58.9 kJ/mol | |
| [Heat Of Vaporization] 99.2 kJ/mol | |
| [Usage] A synthetic corticosteroid. Used for replacement therapy in people whose adrenal glands are not producing enough natural steroids (adrenal insufficiency) and decreasing inflammation in certain disease states. . | |
| [Usage] Metabolic antagonist. | |
| [Product Name] 9a-Fluoro-11b,16a,17a,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide | |
| [Synonyms] 2-Amino-5-methylbenzoic acid 2-Carboxy-4-methylaniline 5-Methyl-2-aminobenzoic acid 5-Methylanthranilic acid 9a-Fluoro-11b,16a,17a,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide 9-a-fluoro-11-b,21-dihydroxy-16-a,17-a-isopropylidenedioxypregna-1,4-diene-3,20-dione 9a-Fluoro-16a,17a-isopropylidenedihydroxyprednisolone 9a-Fluoro-16a-hydroxyprednisolone 16a,17a-acetonide Kenalog Polcortoon | |
| [CAS] "CASEN_2941-78-8.htm">2941-78-8 | |
| [CAS] "CASEN_76-25-5.htm">76-25-5 | |
| [Formula] C24H31FO6 | |
| [Formula] C8H9NO2 | |
| [Molecular Weight] 434.5 | |
| [Molecular Weight] 151.16 | |
| [EINECS] 200-948-7 | |
| [EINECS] 220-932-3 | |
| [RTECS] TU3920000 | |
| [RTECS Class] Drug; Mutagen; Reproductive Effector; Human Data | |
| [Merck] 12,9728 | |
| [Beilstein/Gmelin] 1101527 | |
| [Beilstein/Gmelin] 60069 | |
| [Beilstein Reference] 5-19-06-00568 | |
| [Beilstein Reference] 4-14-00-01357 | |
| [Small spills/leaks] Sweep up, place in a bag and hold for waste disposal. Avoid raising dust. Ventilate area and wash spill site after material pickup is complete. | |
| [Small spills/leaks] Vacuum or sweep up material and place into a suitable disposal container. | |
| [Stability] No data. | |
| [Stability] Stable at normal temperatures and pressures. | |
| [Incompatibilities] Strong oxidizing agents. | |
| [Decomposition] Carbon monoxide, Carbon dioxide, Hydrogen fluoride. | |
| [Decomposition] Carbon monoxide, oxides of nitrogen, carbon dioxide. |
Print